Rapid Micro Biosystems (RPID) Net Income towards Common Stockholders (2020 - 2026)
Rapid Micro Biosystems recorded quarterly Net Income towards Common Stockholders of -$14.3 million in Q1 2026, down 14.23% quarter-over-quarter from -$12.5 million in Q4 2025, and down 26.74% year-over-year from -$19.5 million in Q1 2025.
Rapid Micro Biosystems' Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$14.3 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 26.74% year-over-year to -$14.3 million; the TTM figure through Mar 2026 stood at -$50.1 million (down 11.83% YoY), while the FY2025 annual figure was -$47.1 million, changed 0.5% from the prior year.
- Net Income towards Common Stockholders came in at -$14.3 million for Q1 2026 at Rapid Micro Biosystems, down from -$12.5 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$9.7 million in Q4 2024 to a low of -$16.4 million in Q4 2022.
- A 5-year average of -$13.0 million and a median of -$13.1 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders jumped 38.56% in 2022 and decreased 29.29% in 2025, its largest moves.
- Rapid Micro Biosystems' Net Income towards Common Stockholders stood at -$16.4 million in 2022, then jumped by 32.07% to -$11.2 million in 2023, then increased by 13.48% to -$9.7 million in 2024, then decreased by 29.29% to -$12.5 million in 2025, then decreased by 14.23% to -$14.3 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$14.3 million, -$12.5 million, and -$11.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 | -14.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.28 Mn |
| Dec 31, 2025 | -12.50 Mn |
| Sep 30, 2025 | -11.51 Mn |
| Jun 30, 2025 | -11.86 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Dec 31, 2024 | -9.67 Mn |
| Sep 30, 2024 | -11.32 Mn |
| Jun 30, 2024 | -12.58 Mn |
| Mar 31, 2024 | -13.32 Mn |
| Dec 31, 2023 | -11.17 Mn |
| Sep 30, 2023 | -13.39 Mn |
| Jun 30, 2023 | -14.02 Mn |
| Mar 31, 2023 | -13.89 Mn |
| Dec 31, 2022 | -16.45 Mn |
| Sep 30, 2022 | -16.34 Mn |
| Jun 30, 2022 | -13.09 Mn |
| Mar 31, 2022 | -14.93 Mn |
| Dec 31, 2021 | -14.61 Mn |
| Sep 30, 2021 | -25.23 Mn |
| Jun 30, 2021 | -13.90 Mn |
| Mar 31, 2021 | -24.30 Mn |
| Dec 31, 2020 | -13.61 Mn |
| Sep 30, 2020 | -10.71 Mn |
| Jun 30, 2020 | -11.29 Mn |